L’effet bénéfique de l’expérience mystique dans le trouble dépressif caractérisé à travers l’utilisation de la psilocybine
Cortica September 21, 2024 Alessia Calanchini
Depression is a major public health problem, and current treatments are not always effective, leading to treatment-resistant forms. Over the past twenty years, renewed research on psychedelic substances has shown therapeutic potential for various mental disorders, including depression. This systematic review, following the PRISMA method and including five studies, examines the beneficial impact of the mystical experience induced by psilocybin on depression. The results indicate that the mystical experience plays a role in reducing depression, though inconsistencies remain in the definition of key concepts. Future studies should better define the mystical experience and its potential benefits for depression and other disorders.